Now I have a thorough understanding of the paper. Let me produce the consolidated review.

## Summary

The paper proposes NormIntSleep, a framework that combines deep neural network embeddings with a clinically grounded feature set (FeatShort) via a learned linear projection, enabling interpretable sleep staging using glass-box models like decision trees. The authors also introduce AlignmentDT, a metric to quantify how well a decision tree's splits align with clinical domain knowledge, and demonstrate that NormIntSleep-DecisionTree achieves a perfect AlignmentDT score of 1.0 with 79–82% accuracy, substantially outperforming a purely feature-based decision tree (70–76% accuracy) and other interpretable baselines like SERF (AlignmentDT 0.44). A practicing clinician validated that the decision tree's splits mirror AASM clinical reasoning.

## Strengths

- **Clinician-validated interpretability with competitive accuracy**: A practicing sleep clinician confirmed that the NormIntSleep decision tree's splits — based on beta waves for Wake, EOG crossings, EMG complexity for Wake/N1, EEG kurtosis for REM, slow waves for N3 — follow the AASM manual (Section 5.1). This external validation directly supports the claim that the model produces clinically actionable explanations. Simultaneously, NormIntSleep-DecisionTree achieves 79.1–81.9% accuracy, a substantial improvement over FeatShort-DecisionTree's 69.8–75.8%.

- **Comprehensive benchmarking**: Table 3 evaluates NormIntSleep against 11 methods (including U-Time, DeepSleepNet, AttnSleep, FeatLong, SERF, SLEEPER) on two public datasets (ISRUC and PhysioNet), establishing clear baselines for both interpretable and black-box approaches.

- **SHAP analysis corroborates clinical relevance**: Section 5.3 shows that the top five dimensions of the interpretable embedding (EOG complexity, beta power, EEG variance, etc.) align with known sleep physiology, providing a second, complementary validation beyond the decision tree.

- **Modular framework designed for broader applicability**: NormIntSleep is presented as a domain-agnostic framework with pre-training and glass-box training steps (Algorithms 1 and 2) that could be adapted to other healthcare domains where interpretable features exist.

## Weaknesses

### Fatal
None.

### Major

- **No AlignmentDT score reported for FeatShort-DecisionTree, the critical control.** FeatShort is explicitly constructed from AASM clinical guidelines (Section 3.3). A decision tree trained on FeatShort features naturally tends to split on clinically meaningful attributes. The paper reports AlignmentDT for NormIntSleep-DecisionTree (1.0), FeatLong-DecisionTree (0), and SERF (0.44), but **does not report AlignmentDT for FeatShort-DecisionTree** — the tree that uses the same clinical features without the NormIntSleep projection. Without this comparison, the perfect 1.0 score may simply reflect that FeatShort features are clinically grounded, rather than demonstrating that the NormIntSleep projection adds interpretability value. An ablation comparing AlignmentDT across (a) raw DNN embeddings without projection, (b) FeatShort directly, and (c) permuted/shuffled FeatShort is needed to separate the contribution of the projection from the inherent meaningfulness of the feature set.

- **No analysis of the linear projection's fidelity.** NormIntSleep's critical step is learning a linear mapping from DNN embeddings to FeatShort space via least squares regression (Section 3.1). The paper claims this "transforms DNN embeddings into a domain-grounded interpretable feature space" but provides no diagnostic: What fraction of variance is retained? How accurate is the reconstruction of the handcrafted features from embeddings? Does the projection distort or entangle feature dimensions? The accuracy gain of NormIntSleep-DecisionTree over FeatShort-DecisionTree (6–10%) is attributed to "embedding enrichment," but without projection fidelity analysis, it is unclear whether this gain comes from clinically meaningful information the DNN extracted, or from noise/incidental class separation in the projection.

- **AlignmentDT's operational definition and validation are incomplete.** The paper references "Eq. 1" (line 185) and provides the conceptual framing (score ∈ [0,1], nodes >95% pure are disregarded). However, the paper does not walk through a concrete calculation showing how individual nodes are scored and how the overall score is aggregated. For a new metric central to the paper's contribution, this lack of a worked example makes independent verification and application difficult. Furthermore, the metric measures whether a split's *feature* is clinically relevant, not whether the split's *threshold or behavior* aligns with clinical decision-making — a split on "beta waves" with an arbitrary threshold would still count as aligned. The clinician validation in Section 5.1 partially addresses behavioral alignment for this specific tree, but the metric itself does not capture this.

### Minor

- **Abstract overstates performance comparisons.** The abstract claims "NormIntSleep outperforms prior interpretable techniques," but Table 3 shows FeatLong-CatBoost achieves higher accuracy on ISRUC (0.862 vs. 0.814) and nearly identical results on PhysioNet. The paper acknowledges this in Section 5 ("with the sole exception of the exhaustive feature list present in FeatLong"), but the abstract's wording is imprecise and could mislead readers unfamiliar with the nuance.

- **No measure of statistical uncertainty in the main results.** Results are based on a single 9:1 subject-level split (Section 4.1). While the paper mentions confidence intervals are in Appendices J and I (stripped by the parser), the main text lacks any uncertainty estimates, making it impossible to assess whether observed differences (e.g., FeatLong-CatBoost vs. NormIntSleep-CatBoost on ISRUC) are meaningful.

- **The feature count discrepancy (ISRUC: 121 features, PhysioNet: 52) is explained but its implications for AlignmentDT comparability across datasets are not discussed.** The paper notes that REM features require two EOG channels (available only for ISRUC), but it does not discuss whether the different feature sets affect the comparability of AlignmentDT scores across datasets.

### Trivial
None.

## Nice-to-Haves
- A t-SNE or PCA visualization of the embedding space, FeatShort space, and projected embedding space, colored by sleep stage, to illustrate that the projection retains discriminability and interpretable structure.
- An ablation comparing different regression targets or regularization methods for the linear projector.
- Reporting AlignmentDT for FeatShort-DecisionTree would directly address the most significant control concern.

## Removed Points
These points were raised by one or more reviewers but are removed or downgraded under the review guidelines:

- **"The AlignmentDT equation is missing from the parsed text"** — Removed as a parser artifact; the paper references "Eq. 1" (line 185), confirming the equation exists in the original submission. The substantive concern about insufficient operational detail is preserved in Major weaknesses above.
- **"The paper refers to an appendix for implementation details"** — Removed per guidelines: missing appendix content is a parser artifact, not an author error.
- **"Feature count discrepancy not discussed"** — Partially removed: the paper *does* explain this (different EOG channels across datasets, Section 3.3). The remaining point about cross-dataset comparability of AlignmentDT is preserved in Minor weaknesses.
- **Generalizability concerns based on "not yet released" or "cannot be independently verified"** — None raised that meet this criterion; all cited methods/datasets are treated as existing.

## Novel Insights
The reviews surface a subtle but important tension: the AlignmentDT metric may be measuring the clinical *relevance of the feature set* rather than the *success of the projection* in grounding DNN representations. This is not simply a missing ablation — it cuts to whether NormIntSleep's core claimed advantage (the projection step) is responsible for the interpretability gains, or whether those gains would be achieved by any interpretable model built on FeatShort. The paper's strongest evidence for the projection's value may actually be the accuracy improvement (6–10% over FeatShort-DecisionTree) rather than the AlignmentDT score. Separating these two claims — accuracy improvement from embedding enrichment vs. interpretability improvement from the projection — would substantially strengthen the paper's contribution.

## Suggestions
1. Report AlignmentDT for FeatShort-DecisionTree and for a tree trained on raw DNN embeddings (without projection). This directly tests whether the NormIntSleep projection or the inherent clinical nature of FeatShort drives the perfect score.
2. Provide projection diagnostics: reconstruction error/cosine similarity between true FeatShort and projected embeddings, and a visualization of the embedding/feature space.
3. Include a full worked example of AlignmentDT computation for one branch of the decision tree in Figure 2, showing how each node is scored and how scores are aggregated.
4. Add confidence intervals or report results across multiple data splits to enable assessment of statistical significance.
5. Clarify the abstract to acknowledge that FeatLong-CatBoost achieves comparable or higher raw accuracy (though with less clinically meaningful features).

## Score and Decision

The paper proposes a sensible framework with genuine clinician validation and competitive results. The core methodological weaknesses are that (a) the central metric (AlignmentDT) lacks a controlled comparison against the obvious baseline (FeatShort-DecisionTree's AlignmentDT), (b) the fidelity of the linear projection is unanalyzed, and (c) the metric's operational definition is not fully worked through. These are addressable gaps but they strike at the paper's main claims about interpretability. The paper would be significantly strengthened by addressing them.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>